- Home
- DFH vs SDGR Comparison
DFH vs SDGR Comparison
Compare DFH & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFH
- SDGR
- Stock Information
- Founded
- DFH 2008
- SDGR 1990
- Country
- DFH United States
- SDGR United States
- Employees
- DFH N/A
- SDGR N/A
- Industry
- DFH Homebuilding
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- DFH Consumer Discretionary
- SDGR Health Care
- Exchange
- DFH Nasdaq
- SDGR Nasdaq
- Market Cap
- DFH N/A
- SDGR 1.8B
- IPO Year
- DFH 2021
- SDGR 2020
- Fundamental
- Price
- DFH $22.38
- SDGR $19.67
- Analyst Decision
- DFH Hold
- SDGR Buy
- Analyst Count
- DFH 1
- SDGR 7
- Target Price
- DFH $32.00
- SDGR $32.29
- AVG Volume (30 Days)
- DFH 468.2K
- SDGR 891.3K
- Earning Date
- DFH 05-01-2025
- SDGR 04-30-2025
- Dividend Yield
- DFH N/A
- SDGR N/A
- EPS Growth
- DFH 19.90
- SDGR N/A
- EPS
- DFH 3.34
- SDGR N/A
- Revenue
- DFH $4,451,606,000.00
- SDGR $207,539,000.00
- Revenue This Year
- DFH N/A
- SDGR $28.69
- Revenue Next Year
- DFH $9.49
- SDGR $14.95
- P/E Ratio
- DFH $6.79
- SDGR N/A
- Revenue Growth
- DFH 18.75
- SDGR N/A
- 52 Week Low
- DFH $20.54
- SDGR $16.67
- 52 Week High
- DFH $44.28
- SDGR $29.15
- Technical
- Relative Strength Index (RSI)
- DFH 40.53
- SDGR 39.05
- Support Level
- DFH $23.20
- SDGR $21.34
- Resistance Level
- DFH $24.71
- SDGR $22.85
- Average True Range (ATR)
- DFH 1.07
- SDGR 1.14
- MACD
- DFH -0.25
- SDGR -0.21
- Stochastic Oscillator
- DFH 2.94
- SDGR 5.06
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.